|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 30754 |
FusionGeneSummary for RBM39_WASF2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RBM39_WASF2 | Fusion gene ID: 30754 | Hgene | Tgene | Gene symbol | RBM39 | WASF2 | Gene ID | 9584 | 10163 |
| Gene name | RNA binding motif protein 39 | WAS protein family member 2 | |
| Synonyms | CAPER|CAPERalpha|FSAP59|HCC1|RNPC2 | IMD2|SCAR2|WASF4|WAVE2|dJ393P12.2 | |
| Cytomap | 20q11.22 | 1p36.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | RNA-binding protein 39CAPER alphaRNA-binding region (RNP1, RRM) containing 2coactivator of activating protein-1 and estrogen receptorsfunctional spliceosome-associated protein 59hepatocellular carcinoma protein 1splicing factor HCC1 | wiskott-Aldrich syndrome protein family member 2WASP family Verprolin-homologous protein 2WASP family protein member 2WASP family protein member 4protein WAVE-2putative Wiskott-Aldrich syndrome protein family member 4suppressor of cyclic-AMP recepto | |
| Modification date | 20180519 | 20180522 | |
| UniProtAcc | Q14498 | Q9Y6W5 | |
| Ensembl transtripts involved in fusion gene | ENST00000253363, ENST00000361162, ENST00000528062, ENST00000407261, ENST00000397370, ENST00000463098, | ENST00000430629, ENST00000536657, | |
| Fusion gene scores | * DoF score | 13 X 11 X 8=1144 | 4 X 3 X 3=36 |
| # samples | 15 | 4 | |
| ** MAII score | log2(15/1144*10)=-2.93105264628251 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: RBM39 [Title/Abstract] AND WASF2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF762912 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000253363 | ENST00000430629 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000253363 | ENST00000536657 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000361162 | ENST00000430629 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000361162 | ENST00000536657 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000528062 | ENST00000430629 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000528062 | ENST00000536657 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000407261 | ENST00000430629 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000407261 | ENST00000536657 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000397370 | ENST00000430629 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000397370 | ENST00000536657 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000463098 | ENST00000430629 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
| intron-intron | ENST00000463098 | ENST00000536657 | RBM39 | chr20 | 34330111 | + | WASF2 | chr1 | 27752840 | - |
Top |
FusionProtFeatures for RBM39_WASF2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| RBM39 | WASF2 |
| Transcriptional coactivator for steroid nuclearreceptors ESR1/ER-alpha and ESR2/ER-beta, and JUN/AP-1 (Bysimilarity). May be involved in pre-mRNA splicing process.{ECO:0000250}. | Downstream effector molecule involved in thetransmission of signals from tyrosine kinase receptors and smallGTPases to the actin cytoskeleton. Promotes formation of actinfilaments. Part of the WAVE complex that regulates lamellipodiaformation. The WAVE complex regulates actin filamentreorganization via its interaction with the Arp2/3 complex.{ECO:0000269|PubMed:10381382, ECO:0000269|PubMed:16275905}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RBM39_WASF2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RBM39_WASF2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RBM39_WASF2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RBM39_WASF2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|